Skip to main content
News Icon

News categories: Honors & Funding

Metaflammation SFB being funded

The German Research Foundation is setting up a new Collaborative Research Center (SFB) at the University of Bonn. The SFB 1454 "Metaflammation and Cellular Programming" deals with the connection between a Western lifestyle and chronic inflammatory diseases - for example, how excessive calorie intake coupled with insufficient exercise can promote the development of cardiovascular diseases, neurodegenerative diseases or a metabolic syndrome.

The spokesperson is Prof. Dr. Eicke Latz, who is also spokesperson for ImmunoSensation2. The researchers use a holistic approach to investigate why lifestyle or environmental factors such as obesity, smoking or insufficient exercise influence the incorrect programming of immune cells and thus cause "metaflammation" - a chronic inflammation caused by the immune system.

The scientists are studying how cells interact in inflamed tissue and how molecular signaling pathways contribute to the development of diseases during metaflammation.

The SFB brings together the expertise of scientists from the Faculty of Medicine, the Faculty of Mathematics and Natural Sciences and the Faculty of Philosophy. Researchers from the German Center for Neurodegenerative Diseases (DZNE) in Bonn, the Max Planck Institute for Metabolic Research in Cologne and the "Braunschweig Integrated Center of Systems Biology" are also involved.

Most of the sub-projects of the new SFB are being carried out by scientists from the University Hospital Bonn and the Life and Medical Sciences Institute (LIMES).

"A unique selling point of our Collaborative Research Center is the system immunological approach with which we want to understand complex mechanisms that cause diseases," says Prof. Eicke Latz from the Institute for Innate Immunity at the University Hospital Bonn. On the one hand, these findings are intended to produce new therapeutic approaches and the development of drugs. On the other hand, the newly discovered mechanisms behind the development of metaflammation should provide the necessary knowledge to better prevent common diseases that can be traced back to an unhealthy lifestyle and environmental influences.


Contact

Prof. Dr. Eicke Latz

Institute of Innate Immunity

Phone: +49 (0)228 287 51239 (Secretary)

Eicke.Latz@uni-bonn.de

Related news

PrepAIred

News categories: Honors & Funding

Precise active ingredients against pancreatic cancer

Pancreatic cancer remains one of the deadliest forms of cancer. At the German Cancer Congress 2026, German Cancer Aid is now presenting three large-scale projects that it is funding as part of its “German Alliance for Pancreatic Cancer” funding priority. In the funded project PrepAIred, Bonn researchers , in cooperation with the University of North Carolina (USA), want to use AI-based protein design to specifically combat pancreatic cancer. German Cancer Aid is funding the project with a total of 1.99 million euros over a period of four years.
View entry
Gruppenbild Preistrager Lisec Artz Preisverleihung

News categories: Honors & Funding

Niklas Klümper and Varun Venkataramani receive Lisec-Artz Prize

Dr. Varun Venkataramani of the Faculty of Medicine at Heidelberg University and ImmunoSensation² member Dr. Niklas Klümper of the University Hospital Bonn have been awarded the Lisec Artz Prize for their outstanding cancer research. The University of Bonn Foundation and the University of Bonn Faculty of Medicine presented the awards to the two researchers on Tuesday, November 18, 2025 at the University Hospital Bonn (UKB) as part of the Cluster Science Days event held by the ImmunoSensation² Cluster of Excellence. The prize is worth a total of 15,000 euros.
View entry
20251103 PM Prof Wihelm

News categories: Honors & Funding

Prof. Christoph Wilhelm receives €1.25 million DFG funding for Reinhart-Koselleck project

The German Research Foundation (DFG) is funding a Reinhart-Koselleck project at the University Hospital Bonn (UKB) within the Cluster of Excellence ImmunoSensation² at the University of Bonn with €1.25 million. The research team led by Prof. Christoph Wilhelm, Chair of Immunopathology at the Institute of Clinical Chemistry and Clinical Pharmacology, aims to investigate how the body maintains the balance of the gut microbiome during periods of illness and food scarcity.
View entry

Back to the news overview